2025 Vol.43, N°5 - Table of contents
May 2025
One year in review
CER18647
2025,43,5
Pg. 0799-0808
Free to view
Gout: one year in review 2025
L. Punzi, L. Scagnellato, P. Galozzi, C. Baggio, A. Damasco, F. Oliviero, R. Ramonda
DOI: https://doi.org/10.55563/clinexprheumatol/9sdln5
L. Punzi, L. Scagnellato, P. Galozzi, C. Baggio, A. Damasco, F. Oliviero, R. Ramonda
DOI: https://doi.org/10.55563/clinexprheumatol/9sdln5
Rapid paper
CER18834
2025,43,5
Pg. 0809-0814
Free to view
Immunomodulatory effects of dental pulp stem cells on lymphocytes and monocytes from patients with rheumatoid arthritis
A. Rossi, G. Ferrari, V. Galli, M. Bonacini, G. Carnevale, A. Pisciotta, R. Di Tinco, M. Catanoso, F. Brandolino, C. Galluzzo, A. Zerbini, C. Salvarani, S. Croci
DOI: https://doi.org/10.55563/clinexprheumatol/l64k20
A. Rossi, G. Ferrari, V. Galli, M. Bonacini, G. Carnevale, A. Pisciotta, R. Di Tinco, M. Catanoso, F. Brandolino, C. Galluzzo, A. Zerbini, C. Salvarani, S. Croci
DOI: https://doi.org/10.55563/clinexprheumatol/l64k20
Special Article
CER18707
2025,43,5
Pg. 0815-0821
Free to view
The long journey of artificial intelligence in medicine: an overview
E. Grossi
DOI: https://doi.org/10.55563/clinexprheumatol/oamfed
E. Grossi
DOI: https://doi.org/10.55563/clinexprheumatol/oamfed
CER18695
2025,43,5
Pg. 0822-0828
Free to view
Artificial intelligence software in biomedical imaging: a pharmaceutical perspective on radiology and contrast-enhanced ultrasound applications
G. Valbusa, A. Fringuello Mingo, S. Colombo Serra
DOI: https://doi.org/10.55563/clinexprheumatol/dknvfz
G. Valbusa, A. Fringuello Mingo, S. Colombo Serra
DOI: https://doi.org/10.55563/clinexprheumatol/dknvfz
Full Papers
CER17958
2025,43,5
Pg. 0829-0840
Hydroxychloroquine inhibits the PI3K/AKT pathway in synovial fibroblasts of rheumatoid arthritis and alleviates collagen-induced arthritis in mice
X. Wang, J. He, J. Zhong, J. He, D. Wang, L. Bai, H. Shang, Q. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/tczujg
X. Wang, J. He, J. Zhong, J. He, D. Wang, L. Bai, H. Shang, Q. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/tczujg
CER17109
2025,43,5
Pg. 0841-0846
Free to view
STEp-down approach in MEthotrexate use for the Treatment of Rheumatoid Arthritis (STEMETRA): a pilot study demonstrating efficacy and safety of short-term, high dose methotrexate
M. Pendolino, T. Serban, G. Ferrari, P. Diana, A. Locaputo, D. Camellino, A. Giusti, G. Bianchi
DOI: https://doi.org/10.55563/clinexprheumatol/kv54k5
M. Pendolino, T. Serban, G. Ferrari, P. Diana, A. Locaputo, D. Camellino, A. Giusti, G. Bianchi
DOI: https://doi.org/10.55563/clinexprheumatol/kv54k5
CER17634
2025,43,5
Pg. 0847-0853
Free to view
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients
Y. Yazici, J.R. Tambiah, C.J. Swearingen, V.A. Lopez, S. Kennedy, M.S. Fineman, I. Simsek, E. Solomon, T.E. Mcalindon
DOI: https://doi.org/10.55563/clinexprheumatol/gskbin
Y. Yazici, J.R. Tambiah, C.J. Swearingen, V.A. Lopez, S. Kennedy, M.S. Fineman, I. Simsek, E. Solomon, T.E. Mcalindon
DOI: https://doi.org/10.55563/clinexprheumatol/gskbin
CER17644
2025,43,5
Pg. 0854-0860
Free to view
A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis
Y. Yazici, J.R. Tambiah, C.J. Swearingen, J. Britt, S. Kennedy, M.S. Fineman, I. Simsek, E. Solomon, T.E. Mcalindon
DOI: https://doi.org/10.55563/clinexprheumatol/hjt118
Y. Yazici, J.R. Tambiah, C.J. Swearingen, J. Britt, S. Kennedy, M.S. Fineman, I. Simsek, E. Solomon, T.E. Mcalindon
DOI: https://doi.org/10.55563/clinexprheumatol/hjt118
CER17924
2025,43,5
Pg. 0861-0866
Free to view
Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry
Y. Akasaki, H. Yamada, M. Kondo, J.-I. Fukushi, K. Sakuraba, T. Miyamura, M. Ishida, M. Nakamura, Y. Inoue, T. Tsuru, T. Shuto, S. Yoshizawa, M. Ohishi, K. Kamo, A. Haraguchi, A. Maeyama, Y. Arinobu, H. Mitoma, M. Ayano, N. Ono, T. Fujiwara, D. Hara, R. Yamaguchi, R. Tsurui, K. Yasumoto, T. Natori, T. Sugita, H. Niiro, Y. Nakashima
DOI: https://doi.org/10.55563/clinexprheumatol/7emd6z
Y. Akasaki, H. Yamada, M. Kondo, J.-I. Fukushi, K. Sakuraba, T. Miyamura, M. Ishida, M. Nakamura, Y. Inoue, T. Tsuru, T. Shuto, S. Yoshizawa, M. Ohishi, K. Kamo, A. Haraguchi, A. Maeyama, Y. Arinobu, H. Mitoma, M. Ayano, N. Ono, T. Fujiwara, D. Hara, R. Yamaguchi, R. Tsurui, K. Yasumoto, T. Natori, T. Sugita, H. Niiro, Y. Nakashima
DOI: https://doi.org/10.55563/clinexprheumatol/7emd6z
CER18297
2025,43,5
Pg. 0867-0873
Free to view
Clinical outcomes in cancer patients with immune checkpoint inhibitor-induced arthritis treated with methotrexate: a retrospective longitudinal monocentric pilot study
E. Hysa, A. Casabella, N. Iandolino, E. Gotelli, C. Genova, E.T. Tanda, C. Pizzorni, V. Smith, A. Sulli, M. Cutolo, S. Paolino
DOI: https://doi.org/10.55563/clinexprheumatol/e49am5
E. Hysa, A. Casabella, N. Iandolino, E. Gotelli, C. Genova, E.T. Tanda, C. Pizzorni, V. Smith, A. Sulli, M. Cutolo, S. Paolino
DOI: https://doi.org/10.55563/clinexprheumatol/e49am5
CER18199
2025,43,5
Pg. 0874-0879
Macrophage requirements for abatacept response in rheumatoid arthritis
B. De Maleprade, B. Gérard, P. Brevet, G. Riou, S. Candon, O. Boyer, O. Vittecoq, T. Lequerré, M. Fréret
DOI: https://doi.org/10.55563/clinexprheumatol/s42d3g
B. De Maleprade, B. Gérard, P. Brevet, G. Riou, S. Candon, O. Boyer, O. Vittecoq, T. Lequerré, M. Fréret
DOI: https://doi.org/10.55563/clinexprheumatol/s42d3g
CER18234
2025,43,5
Pg. 0880-0888
Free to view
Comparison of the efficacy of Janus kinase inhibitors and adalimumab in rheumatoid arthritis: a meta-analysis
Q. Zhou, S. Zhu, S. Dai, Q. Wu, J. Zheng, H. Zhu, W. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/4g8g9q
Q. Zhou, S. Zhu, S. Dai, Q. Wu, J. Zheng, H. Zhu, W. Yang
DOI: https://doi.org/10.55563/clinexprheumatol/4g8g9q
CER18322
2025,43,5
Pg. 0889-0896
Psoriatic arthritis phenotype may vary depending on whether the skin or joint domain appears first or whether both appear simultaneously
R. Queiro, P. Alvarez, N. Calleja, I. Braña, S. Burger, E. Pardo, M. Loredo, S. Alonso, V. Chiminazzo, M. Alperi
DOI: https://doi.org/10.55563/clinexprheumatol/8gl4ja
R. Queiro, P. Alvarez, N. Calleja, I. Braña, S. Burger, E. Pardo, M. Loredo, S. Alonso, V. Chiminazzo, M. Alperi
DOI: https://doi.org/10.55563/clinexprheumatol/8gl4ja
CER18105
2025,43,5
Pg. 0897-0906
Free to view
Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion
M. Manara, A. Carriero, M. Congia, C. Galluzzo, M. Pandolfi, M. Salvato, S. Scriffignano, A. Cauli, S. D'angelo, E. Lubrano, R. Ramonda, C. Salvarani, A. Marchesoni
Collaborator/s: F. Atzeni, C. Baldi, S. Bellando Randone, F. Caso, M.S. Chimenti, A. Delle Sedie, S. Gentileschi, N. Girolimetto, G. Guidelli, L. Idolazzi, A. Lo Gullo, M. Lorenzin, M.M. Luchetti, A. Ortolan, V. Picerno, F.M. Perrotta, N. Possemato, R. Scrivo, C. Selmi, F. Sensi, V. Venerito
Study Group on Spondyloarthritis and Psoriatic Arthritis ‘Antonio Spadaro’ of the Italian Society for Rheumatology
DOI: https://doi.org/10.55563/clinexprheumatol/j7b6t5
M. Manara, A. Carriero, M. Congia, C. Galluzzo, M. Pandolfi, M. Salvato, S. Scriffignano, A. Cauli, S. D'angelo, E. Lubrano, R. Ramonda, C. Salvarani, A. Marchesoni
Collaborator/s: F. Atzeni, C. Baldi, S. Bellando Randone, F. Caso, M.S. Chimenti, A. Delle Sedie, S. Gentileschi, N. Girolimetto, G. Guidelli, L. Idolazzi, A. Lo Gullo, M. Lorenzin, M.M. Luchetti, A. Ortolan, V. Picerno, F.M. Perrotta, N. Possemato, R. Scrivo, C. Selmi, F. Sensi, V. Venerito
Study Group on Spondyloarthritis and Psoriatic Arthritis ‘Antonio Spadaro’ of the Italian Society for Rheumatology
DOI: https://doi.org/10.55563/clinexprheumatol/j7b6t5
CER18113
2025,43,5
Pg. 0907-0916
RBM15, an m6A enzyme, suppresses NLRP3 inflammasome activation in rheumatoid arthritis through macrophage metabolism
M. Yu, J. Wu, S. Zhang, W. Yan, S. Kong, J. Peng
DOI: https://doi.org/10.55563/clinexprheumatol/uecchi
M. Yu, J. Wu, S. Zhang, W. Yan, S. Kong, J. Peng
DOI: https://doi.org/10.55563/clinexprheumatol/uecchi
CER18251
2025,43,5
Pg. 0917-0923
Tixagevimab-cilgavimab for the prevention of COVID-19: real-world experience in patients with rheumatic diseases receiving rituximab
C.C. Mok, M.H. Leung, K.M. Chan, K.Y. Ying, T.K. Ho, W.N. Lao, K.L. Lee, H. So, W.L. Ng, L.Y. Ho, K.Y. Young, C.H. To
DOI: https://doi.org/10.55563/clinexprheumatol/rd87jm
C.C. Mok, M.H. Leung, K.M. Chan, K.Y. Ying, T.K. Ho, W.N. Lao, K.L. Lee, H. So, W.L. Ng, L.Y. Ho, K.Y. Young, C.H. To
DOI: https://doi.org/10.55563/clinexprheumatol/rd87jm
CER18227
2025,43,5
Pg. 0924-0930
Matrix metalloproteinase-12, an indicator potentially contributing to the differential diagnosis and activity assessment of retroperitoneal fibrosis
T. Zheng, X. Zhang, J. Gao, X. Zhang, J. Zhao, S. Liu, H. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/ys972g
T. Zheng, X. Zhang, J. Gao, X. Zhang, J. Zhao, S. Liu, H. Gao
DOI: https://doi.org/10.55563/clinexprheumatol/ys972g
CER18015
2025,43,5
Pg. 0931-0938
Free to view
Effect of TNF-α blockers on reducing the risk of dementia in rheumatoid arthritis: a nationwide cohort study
L.-F. Chen, T.-M. Lin, Y.-S. Chang, H.-C. Hsu, Y.-C. Shen, S.-H. Lin, W.-S. Chen, L.-F. Hu, P.-I. Kuo, T.-T. Kuo, S.-C. Chen, J.-H. Chen, Y.-K. Lien, C.-C. Chang
DOI: https://doi.org/10.55563/clinexprheumatol/6oto0h
L.-F. Chen, T.-M. Lin, Y.-S. Chang, H.-C. Hsu, Y.-C. Shen, S.-H. Lin, W.-S. Chen, L.-F. Hu, P.-I. Kuo, T.-T. Kuo, S.-C. Chen, J.-H. Chen, Y.-K. Lien, C.-C. Chang
DOI: https://doi.org/10.55563/clinexprheumatol/6oto0h
Review
CER18145
2025,43,5
Pg. 0939-0945
Acute coronary syndromes in young lupus patients, shifting the view on the old problem
S. Ajeganova
DOI: https://doi.org/10.55563/clinexprheumatol/ykkcja
S. Ajeganova
DOI: https://doi.org/10.55563/clinexprheumatol/ykkcja
Paediatric Rheumatology
CER17763
2025,43,5
Pg. 0946-0952
Free to view
Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors
M.M. Riskalla, F.A. Barbar-Smiley, N.A. Marka, M.A. Lerman
the CARRA Registry investigators
DOI: https://doi.org/10.55563/clinexprheumatol/08z0v4
M.M. Riskalla, F.A. Barbar-Smiley, N.A. Marka, M.A. Lerman
the CARRA Registry investigators
DOI: https://doi.org/10.55563/clinexprheumatol/08z0v4
Letters to the Editor
CER17952
2025,43,5
Pg. 0953-0954
Free to view
Hypereosinophilic syndrome with Löffler endocarditis in a patient with Rhupus syndrome
A. Mayo-Juanatey, C. Valera-Ribera, C. Gil-Llopis, E. Esteban-Esteban, J. Vizuete-Del río, J.J. Alegre-Sancho
DOI: https://doi.org/10.55563/clinexprheumatol/zomy8p
A. Mayo-Juanatey, C. Valera-Ribera, C. Gil-Llopis, E. Esteban-Esteban, J. Vizuete-Del río, J.J. Alegre-Sancho
DOI: https://doi.org/10.55563/clinexprheumatol/zomy8p
CER18541
2025,43,5
Pg. 0955-0956
Free to view
Risk of cervical intraepithelial neoplasia during Janus kinase inhibitor treatment in patients with rheumatoid arthritis: a retrospective cohort study
M.R. Cho, Y.-E. Kim, Y.-J. Lee, S.M. Ahn, Y.-G. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/3s2g9s
M.R. Cho, Y.-E. Kim, Y.-J. Lee, S.M. Ahn, Y.-G. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/3s2g9s